Product Description: JYQ-194 is a PROTAC degrader targeting human Parkinson's disease protein 7 (PARK7). JYQ-194 can be used in the study of cancer and neurodegenerative diseases. (Pink: PARK7 ligand (HY-163563); Black: linker (HY-W017440); Blue: E3 ligase ligand (HY-10984))[1].
Applications: Cancer-programmed cell death
Formula: C39H38FN11O8S
References: [1]Jia Y, et al. Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell[J]. Journal of Medicinal Chemistry, 2024.
Molecular Weight: 839.85
Research Area: Cancer; Neurological Disease
Target: PROTACs